Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WuXi AppTec | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥137.46B | 16x | -2.48 | CN¥50.22 | 4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.5% Upside | Upgrade to Pro+ | |
Hangzhou Tigermed Consulting | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥55.12B | 49.2x | -0.92 | CN¥64 | 7.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7% Upside | Upgrade to Pro+ | |
Pharmaron Beijing | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥48.91B | 25.2x | 1.07 | CN¥27.51 | 7.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.3% Downside | Upgrade to Pro+ | |
Shanghai Allist Pharmaceuticals Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥22.76B | 19.4x | 0.08 | CN¥54.88 | 8.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BGI Genomics | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥17.57B | 311.2x | -3.71 | CN¥46.06 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dizal Jiangsu Pharmaceutical | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥17.29B | -15.5x | 8 | CN¥44 | 5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.8% Upside | Upgrade to Pro+ | |
Sinocelltech Group | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥16.15B | -122.4x | -1.89 | CN¥38.10 | 5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
RemeGen | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥12.81B | -3.3x | 0.26 | CN¥31.22 | 6.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.4% Downside | Upgrade to Pro+ | |
Beigene | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥12.73B | -3.4x | -0.69 | CN¥180.21 | 5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.7% Upside | Upgrade to Pro+ | |
Joinn Laboratories China | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥12.72B | 90.6x | -1.03 | CN¥16.94 | 5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.5% Downside | Upgrade to Pro+ | |
InnoCare Pharma | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥12.28B | -21x | -1.11 | CN¥13.97 | 7.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mabwell Shanghai Bioscience | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥9.39B | -10.1x | 0.71 | CN¥24.90 | 6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bio-Thera Solutions | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥9.03B | -22.1x | -0.77 | CN¥23.40 | 7.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.2% Upside | Upgrade to Pro+ | |
Sino Biological | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥8.35B | 36.5x | -2.18 | CN¥69.54 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.7% Upside | Upgrade to Pro+ | |
InventisBio | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.51B | -12.9x | -0.71 | CN¥10.08 | 5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GemPharmatech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.92B | 28.7x | CN¥12.57 | 4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.1% Upside | Upgrade to Pro+ | ||
Beijing Kawin Technology Shareholding Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.69B | 27.8x | 0.82 | CN¥28.65 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.9% Upside | Upgrade to Pro+ | |
R G PharmaStudies | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥4.57B | 23x | 2.03 | CN¥49.83 | 4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.6% Upside | Upgrade to Pro+ | |
HitGen | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.45B | 70.4x | 1.37 | CN¥11.60 | 4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6% Upside | Upgrade to Pro+ | |
Hangzhou BioSincerity PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥4.44B | 18.1x | 0.6 | CN¥42.77 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beijing Sun Novo Pharmaceutical Research | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.36B | 22.6x | 1.32 | CN¥41.66 | 6.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shanghai Medicilon | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.26B | -12x | 0.1 | CN¥34.95 | 9.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shanghai Aladdin Biochemical Technology Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.63B | 24.1x | 0.57 | CN¥13.06 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.4% Upside | Upgrade to Pro+ | |
Jiangsu Asieris Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.41B | -7.4x | 0.55 | CN¥6.30 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Guangzhou Boji Medical & Biotech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.33B | 89.6x | 4.7 | CN¥8.78 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.5% Upside | Upgrade to Pro+ | |
PharmaResources Shanghai | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.27B | 165.7x | -2.05 | CN¥24.46 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hinova Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.26B | -10.7x | -0.5 | CN¥34.60 | 5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ChemPartner PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.12B | -3.1x | 0.04 | CN¥6.26 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Qingdao Vland Biotech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.06B | 35.2x | 1.06 | CN¥11.90 | 4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anhui Wanbang Pharmaceutical | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥2.70B | 20.2x | -1.01 | CN¥41.78 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |